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Introduction 
Atrial fibrillation is the most common sustained cardiac arrhythmia1 and 
represents the most common clinically significant cardiac arrhythmia2. 
Atrial fibrillation is characterized by uncoordinated supraventricular 
(Atrial) activation associated with an irregular rapid ventricular response. 
Consequently, this irregularly irregular rhythm leads to deterioration of normal 
atrial mechanical function. Although the prevalence of atrial fibrillation remains 
under one percent in general population for those who are less than 60 years old, it 
is estimated to affect 6 to 10 percent of people above 80   years of age3. It has been 
clearly shown that the presence of atrial fibrillation may convey significant 
morbidity and mortality4. 
Atrial fibrillation is the most common arrhythmia that requires treatment 
and it crosses the path of almost all clinicians. Although the majority of patients 
with atrial fibrillation are relatively asymptomatic, patients can have profoundly 
limiting symptoms due to rapid or slow basal ventricular rates, a rapid cardio 
accelerator response to exercise, beat to beat irregularity with associated 
palpitations, and the loss of atrial systolic contribution to ventricular filling lead to 
diminished cardiac output. In addition, there is a propensity for left atrial thrombus 
with subsequent morbidity in the form of embolic stroke. For these reasons there 
 has been a strong impetus to improve our knowledge and understanding of atrial 
fibrillation and its response to therapeutic interventions5. 
Underlying causes of atrial fibrillation are structural heart diseases, and 
these compose most of the atrial fibrillation population. The most common 
cardiovascular pathologies associated with presence of atrial fibrillation in general 
population are valvular (mainly mitral) heart diseases, hypertension, coronary 
artery disease, congestive heart failure6. 
One population study has suggested that atrial fibrillation associated with 
different underlying structural abnormalities has a different age of first clinical 
appearance. Atrial fibrillation secondary to the valvular heart disease manifests 
approximately 15 years earlier than atrial fibrillation associated with hypertension 
or coronary artery disease7. 
HYPOTHESIS   
Because of the poor understanding of the mechanism of atrial fibrillation, it 
routinely is classified as a single arrhythmia, but this is probably not the case, as 
many substrates and mechanisms may be responsible for a common ECG 
manifestation of atrial fibrillation. Just in the past decade, with the advancement of 
the technology used for atrial fibrillation mapping, understanding the 
pathophysiology of atrial fibrillation has grown immensely. 
 From the multiple wavelet theory that was first introduced by Moe and later 
confirmed through mapping by Allersie et al to the computer simulations of spiral 
waves and high frequency periodic sources seen with optical mapping, which have 
led to the development of mother rotor theory, controversy remains as to the 
pathophysiology of atrial fibrillation8. 
Atrial fibrillation carries a substantial risk of thromboembolism that also 
increases precipitously in the elderly (4 to 5 folds). Clinical risk factors have been 
identified from the stroke prevention in atrial fibrillation (SPAF TRIAL) trial. 
These include     
1. Previous thromboembolism   
                 2. Hypertension  
                 3. Poor LV function, and 
                 4. Age >75 years  
Echocardiography has been helpful in further defining risks. Transthoracic echo 
cardiographic risk factors that were identified in SPAF trial include 
1. LA size 
2. LV dysfunction  
In fact echo variables altered thromboembolic risk in 18% of the entire cohort 
study and in 38% of those with out any clinical risk factors9. 
   Transesophageal echocardiography (TEE) offers unique imaging resolution 
of the left atrium and its appendages and is an excellent tool for detecting embolic 
sources. In SPAF trial 41% of patients underwent TEE examination. 
Transesophageal echocardiographic features that were independently associated 
with increased thromboembolic risk in patients taking aspirin were, appendage 
thrombi, dense spontaneous echo contrast, left atrial appendage peak flow 
velocities <20 cm\sec, and complex aortic plaque10. 
           This study was done to evaluate the common causes of atrial fibrillation in 
our population and evaluate them clinically and by means of Transthoracic and 
Transesophageal echocardiography. 
 
 
 
 
 
 
 
 
 
  
                                            Review of literature 
Perhaps the earliest description of atrial fibrillation is in the Yellow 
emperor’s classic of internal medicine (Huang ti neiching suken). The legendary 
emperor physician is believed to have ruled China between 1696 and 2598 B.C. 
The poor prognosis associated with chaotic irregularity of the pulse was clearly 
acknowledged by most of the ancient physicians but in recorded history, William 
Harvey in 1628 was probably the first to describe “fibrillation of auricles” in 
animals1. 
In clinical practice, with the aid of Lannec’s recently invented stethoscope, 
Robert Adams reported in 1827 the association of irregular pulses with mitral 
stenosis in 1863; Eitiene Marey published a pulse tracing with mitral stenosis. 
Other early descriptions of atrial fibrillation and its importance were published 
early in the century by Sir James Mackenzie and Heinrich Hering. The discovery 
of therapeutic properties of digitalis leaf (Digitalis purpurea) in 1785 by William 
Withering brought some relief to patients with severe heart failure. It is interesting 
to note that Withering recorded a patient who had a weak, irregular pulse that 
became “more full and regular” after five draughts containing Fol digital purp oz 
intravenous. 
 The main diagnostic breakthrough was the invention of the 
electrocardiography by William Einthoven in 1900. Sir Thomas Lewis at 
University college hospital was the first to record an electrocardiogram in a patient 
with atrial fibrillation.                                       
History of atrial fibrillation1 
1827 Adams, probably the first to recognize the 
condition clinically, but as a sign of mitral 
stenosis.  
1839  Hope identified irregular pulse in association 
with mitral stenosis, exercise worsened the total   
irregularity, where as it abolished an                                            
intermittent pulse. 
1863                                     Marey published a pulse tracing of atrial 
fibrillation from a patient with Mitral stenosis  
1874                                       Vulpian, observed atrial fibrillation  
                                              In vivo. 
1894                                      Engelmann reported atrial fibrillation   
                                              Caused by multiple foci in atria 
1900                                      Einthoven invented ECG. 
1909                                      Lewis recorded atrial fibrillation with 
Electrocardiography and studied mechanisms of 
conduction. Winterburg and Rothenburg 
identified “arrhythmia perpetua” and 
“fibrillation of auricles”. 
 1935                                      Bouilland found that digitalis reduced 
                                              the ventricular rate dramatically even 
                                              though irregularity of pulse persisted. 
1969                                      Lown recommended cardio version of    
                                              atrial fibrillation. 
 
Epidemiology  
Atrial fibrillation is common in the community, affecting up to 5% of the 
people aged 75 years. It is a major reason for emergency admissions and cause of 
cardiovascular deaths. Thus most clinicians in hospital and general practice will 
participate in managing such patients. As the prevalence of the condition increases 
with age, atrial fibrillation will become increasingly common in the increasingly 
aging population. 
                      Epidemiological studies have shown that atrial fibrillation is fairly 
uncommon in people aged less than 50 years but is found in 0.5% of population 
aged 50 to 59 years, increasing to 8.8% at age 80 to 89 years. Furthermore the 
arrhythmia may be either chronic or paroxysmal. In the Framingham study, 
hypertension, cardiac failure and rheumatic heart disease were the commonest 
precursors of atrial fibrillation. Commonest causes in western countries include 
coronary artery disease, hypertension and rheumatic and non rheumatic valvular 
heart diseases.                       
 In contrast, in developing countries Rheumatic heart disease is by far the 
most common cause of atrial fibrillation. The prevalence of Rheumatic heart 
disease in India is about 3.2% while study undertaken by CMC Vellore Hospital in 
the population living in and around Vellore has shown a prevalence rate of 0.69%. 
From the available data it could be said that Rheumatic heart disease constitutes a 
very important etiology for atrial fibrillation. 
Importance                     
Because of serious implications of atrial fibrillation, clinicians in all 
specialties as well as hospitals and primary health care nurses must be trained 
adequately in its detection and management. The sudden onset of fast atrial 
fibrillation may precipitate overt heart failure, particularly if left ventricular 
function is already compromised by the co existing heart diseases, such as valvular 
or ischemic heart disease. Less dramatic presentation of atrial fibrillation includes 
palpitation, dyspnea, angina, general fatigue and lethargy. Symptoms may be more 
pronounced on exercise, with a greatly limited exercise tolerance. 
More important is however, the finding that non rheumatic atrial fibrillation 
increases the risk of stroke by a factor of five. The risk of stroke in atrial 
fibrillation is about 5% per year and epidemiological studies suggest that the risk 
increases with age, blood pressure, and other evidence of heart diseases. Atrial 
fibrillation may also increase the risk of recurrent stroke. 
    
 Definition 
Atrial fibrillation is a supraventricular tachyarrhythmia characterized by 
uncoordinated atrial activation with consequent deterioration of atrial mechanical 
function.11, 12  
On the electrocardiogram atrial fibrillation is described by the replacement 
of consistent p waves by rapid oscillations with an irregular, frequently rapid 
ventricular response when atrioventricular conduction is intact. The ventricular 
response to atrial fibrillation depends on electrophysiological properties of the  
A-V node, the level of vagal and sympathetic tone, and the actions of drugs. 
Regular R-R intervals are possible in the presence of A-V block or interference 
due to ventricular or junctional tachycardia. In the patients with ectopic pace 
makers, diagnosis of atrial fibrillation may require temporary inhibition of the 
pace maker to expose atrial fibrillatory activity. A rapid irregular, sustained, wide 
QRS complex tachycardia strongly suggests atrial fibrillation with conduction 
over an accessory pathway or atrial fibrillation with underlying bundle branch 
block. Extremely rapid rates (over 200 bpm) suggest the presence of an accessory 
pathway12. 
 
 
 
  
Figure 1. 
ECG of Atrial fibrillation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Diagnosis and screening for atrial fibrillation 
Electrocardiogram and its limitations 
The resting electrocardiogram remains the main stay diagnostic tool for 
diagnosis of atrial fibrillation. ECG is easy to perform and inexpensive, however 
the paroxysmal and frequently asymptomatic nature of atrial fibrillation in most 
patients limits the value of usual 12 lead ECG as a screening test of atrial 
fibrillation. Negative single surface ECG therefore has limited sensitivity, which 
may be improved by ECG monitoring (Holter loop recorder). In patients having 
pacemaker implanted, there is a unique possibility of monitoring the intra atrial 
electro cardiograms. It may be difficult however to extrapolate the data obtained 
from the devices with an atrial electrode, because many of the indications for 
implantation of a device are associated with increased incidence of atrial 
fibrillation. Also existence of atrial electrode itself may increase the risk of the 
chance of having atrial fibrillation in the future13, 14. 
Classification 
                     A variety of the nomenclature terms have previously been used to 
describe atrial fibrillation, including “lone atrial fibrillation”, idiopathic atrial 
fibrillation” and non valvular atrial fibrillation. The most recently executive 
summary endorsed by the American College of Cardiology, the American Heart 
Association, the European Society of Cardiology, and the North American Society 
 of Pacing and Electrophysiology had classified atrial fibrillation as, paroxysmal, 
persistent and permanent.14,15,16 These terms are defined below: 
                        1. Paroxysmal: recurrent, intermittent atrial fibrillation that 
previously terminated with out specific therapy. Paroxysmal atrial fibrillation is 
self limited. 
                         2. Persistent: recurrent, sustained atrial fibrillation that was 
previously terminated by therapeutic intervention. Persistent atrial fibrillation may 
be the first presentation, a culmination of recurrent episodes of paroxysmal atrial 
fibrillation or long lasting atrial fibrillation (greater than one year). Persistent atrial 
fibrillation is not self limited, but may be converted to sinus rhythm by medical or 
electrical interaction. 
                         3. Permanent: continuous atrial fibrillation which cannot be 
converted to normal sinus rhythm by pharmacological or electrical techniques. 
                           In the Cox classification system, if atrial fibrillation is present all  
the time, it is defined as continuous atrial fibrillation and if the atrial fibrillation is 
not present all the time, it is defined as intermittent atrial fibrillation. This 
important distinction is directly linked to the therapeutic decision making. Simple 
pulmonary vein encirclement may provide an adequate cure for those patients with 
intermittent atrial fibrillation, since in this subset of patients; pulmonary veins 
usually provide the necessary aberrant electrical signals. However for patients 
 with continuous atrial fibrillation simple pulmonary vein isolation procedure is not 
usually adequate therapy. 
Factors that contribute to Atrial fibrillation       
 Potentially reversible causes of AF 
Electrolyte abnormalities 
Intoxicants: alcohol, carbon monoxide 
Cardiothoracic surgery 
Electrocution 
Pulmonary embolism 
Other pulmonary diseases 
Hyperthyroidism 
Cardiovascular diseases associated with AF 
Systemic hypertension 
Congestive heart failure 
Valvular heart disease 
Inflammatory atrial disease: myocarditis, pericarditis 
Infiltrative atrial disease: amyloidosis, age-related fibrotic changes 
Coronary artery disease 
 Primary or metastatic disease involving the atrial wall 
Congenital heart disease: atrial septal defect, Ebstein’s anomaly, 
Postsurgical repair 
Neurogenic and autonomically mediated causes of AF 
Heightened vagal tone 
Heightened adrenergic tone, resulting from anxiety, 
Pheochromocytoma, exertion 
Subarachnoid hemorrhage 
Basic Mechanisms and Genetics 
                   Because of the poor understanding of the mechanisms of atrial 
fibrillation it is routinely classified as a single arrhythmia, but it probably is not 
the case as many substrates and mechanisms may be responsible for a common 
ECG manifestation of atrial fibrillation. Just in the past decade with the advent of 
technology used for atrial fibrillation mapping, understanding of pathophysiology 
of atrial fibrillation has grown immensely. From the Multiple wavelet theory that 
was first introduced by Moe et al18 and later confirmed through mapping by 
Allersie et al19, to computer simulations of spiral waves and high frequency 
periodic sources seen with optical mapping which have led to the development of 
the “Mother rotor theory”, controversy remains as to the pathophysiology of atrial 
fibrillation8. 
 Figure 2 
 
 
 
 
Figure 2 Activation maps recorded during acute and chronic AF with high-
density epicardial plaque electrodes. The gray regions indicate areas that 
were not in contact with the atria. Both the acute and chronic AF maps 
show that the AF in this model is composed of multiple wavelets. 
 
 
  
 
Specific mechanisms  
Multiple wavelets Theory 
The idea that, electrical impulses could have re-entrant characteristics was first 
proposed by Mayer in two papers that were published in 1906 and in 1908. In 
these two studies rings of tissue from jelly fish were used for study. 
Lewis suggested that atrial fibrillation was composed of a single re -entrant circuit 
with varying durations. The mechanism of atrial fibrillation was considered to be 
due to either circuit movement of re -entry or a variation of this theory, until Moe 
proposed the theory that atrial fibrillation was caused by multiple, random re-
entrant wavelets. The more wavelets that existed, the more likely the fibrillation 
would continue. This hypothesis was regarded widely as the mechanism of atrial 
fibrillation, and it gained support when Allersie et al showed that based on high 
density mapping of a canine heart during atrial fibrillation, its mechanism was 
multiple wavelets. They concluded that four to six wavelets are needed for 
continuation of atrial fibrillation8. 
Mother rotor theory: 
A rotor has been defined as a stable rotating pattern of reaction and 
diffusion that surrounds a pivot point, also known as a phase singularity. A curved 
wave front radiates from the rotor into the surrounding tissues20. 
 Optical movies were examined and the isochronal maps constructed and it was 
determined that these high frequency sources were a vortex rotating clockwise. 
This rotor lasted for the entire episode of atrial fibrillation. Because the frequency 
of the rotor was the highest frequency of all recorded sites, it was determined that 
the rotor was driving the atrial fibrillation. Hence a mother rotor was defined as a 
stable, high frequency source that appears to be driving the atrial fibrillation. All 
of these high frequency sources were found in the left atrium suggesting that the 
left atrial activity was driving the atrial fibrillation. 
 Pulmonary veins and focal source  
Until recently it was believed widely that the multiple re -entrant wave 
fronts associated with atrial fibrillation did not have a single point of origin, but 
recent studies have demonstrated that paroxysmal atrial fibrillation can have a 
focal source and the pulmonary veins plays a major role in the origin of the focal 
source21. Haissagurre et al showed that 94% of the single point origin was 
identified as originating from the pulmonary veins with the earliest activation 
occurring 2 to 4 cm with in pulmonary veins. 
               The mechanism of atrial fibrillation remains controversial as support still 
exists for multiple wavelets, “mother rotor” and focal sources. These mechanisms 
need not be mutually exclusive. For example, the mother rotor hypothesis may not 
be distinct from the focal atrial fibrillation, if the rotor is of small size (i.e. micro-
entry). It is likely that there is not one mechanism for all atrial fibrillation, but that 
 there are substrate specific mechanisms and that atrial fibrillation may be 
comprised of several different mechanisms. 
            Genetic studies showed that mutations in GJA5 genes may 
predispose patients to idiopathic atrial fibrillation by impairing gap junction 
assembly or electrical coupling. The cardiac gap junction protein connexin-40 is 
expressed selectively in atrial myocytes and mediates the coordinated electrical 
activation of the atria. Hence the tissue specific mutations in GJA5, the gene 
coding connexin-40, may predispose the atria to fibrillation22. 
                          
 
 
 
 
 
 
 
 
 
 
 Clinical evaluation 
           The initial evaluation of a patient with atrial fibrillation begins with a 
thorough history focused on identifying precipitants, defining associated cardiac 
and extra cardiac factors, and characterizing the pattern of arrhythmia (e.g. 
symptoms, duration, paroxysmal vs. persistent, first episode vs. recurrent etc ). 
Physical examination typically reveals an irregularly irregular pulse, irregular 
jugular venous pulsations with absent “A waves” and variations in the intensity of 
the first heart sound23. Associated valvular disease, primary or secondary (i.e. 
tachycardia induced) cardiomyopathies, or heart failure may be identified. The 
definite diagnosis of atrial fibrillation requires at least one ECG lead documenting 
the arrhythmia from a rhythm strip, standard 12 lead ECG, holter monitoring, or 
transtelephonic or telemetric recording. If episodes are infrequent an external or 
internally implanted event recorder may allow the patient to transmit the stored 
ECG to a recording facility when symptoms occur24.    
 RISK OF EMBOLISATION 
                   In addition to hemodynamic alterations, the risk of systemic emboli, 
probably arising in the left atrial cavity or appendage as a result of circulatory 
stasis, is an important consideration. 
                   In United States Non valvular atrial fibrillation is the most common 
cardiac disease associated with cerebral embolism. In fact almost half of 
cardiogenic emboli in United States occur in patients with non valvular atrial 
fibrillation. The risk of stroke in patients with non valvular atrial fibrillation is five 
to six times greater than in controls without atrial fibrillation. Over all 20 to 25 
percent of ischemic strokes are due to cardiogenic emboli25. 
Table 126    
Risk Factors (Control Groups) Relative Risk 
Previous stroke or TIA 2.5 
History of hypertension 1.6 
Congestive heart failure 1.4 
Advanced age (continuous, per decade) 1.4 
Diabetes mellitus 1.7 
Coronary artery disease 1.5 
From ACC/AHA/ESC Guidelines for the Management of Patients with Atrial 
Fibrillation, 2002. 
Table shows the risk factors for thromboembolism in patients with atrial 
fibrillation. 
  
 
Figure 3
Age-Adjusted Relative Risk of Stroke in Atrial
Fibrillation With CHF or CHD
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Risk factors that predict stroke in patients with non valvular atrial fibrillation 
include a history of previous stroke or transient ischemic attack (relative risk 2.5), 
diabetes (relative risk 1.7) history of hypertension (relative risk 1.6) and increasing 
age (relative risk 1.4 for each decade). Patients with any of these risk factors have 
an annual stroke risk of at least 4 percent if untreated. Patients whose only stroke 
risk factor is congestive heart failure or coronary  artery disease have stroke rates 
approximately three times higher than do patients with out any risk factors. Left 
ventricular dysfunction and a left atrial size greater than 2.5 cm\m2 on 
echocardiographic examination are associated with thromboembolism. Patients 
younger than 60 to 65 years of age who have a normal echocardiography and no 
risk factors have an extremely low risk of stroke (1 percent per year). Therefore 
the risk of stroke in patients with lone atrial fibrillation in the absence of any 
structural heart disease or any of the risk factors discussed previously is quite low. 
                   But these datas are from western part of the globe and unfortunately 
we don’t have sufficient data or clinical trials regarding atrial fibrillation in India, 
predominantly caused by valvular heart diseases particularly that of mitral valve. 
Patients with mitral stenosis and atrial fibrillation have a 4 to 6 percent incidence 
of embolism per year. 
       
  
Table 2 
Stroke and Atrial Fibrillation according to Age 
– Framingham Study 
Age (yr) % Strokes with AF % Strokes
Attributed to AF
1.5
2.8
9.9
23.5
6.5
8.5
18.8
30.7
50-59
60-69
70-79
80-89
 
The Framingham study in the table 2 clearly shows the increasing percentage of 
stroke with atrial fibrillation, with increasing age. But this study was conducted 
among the western population with predominantly non valvular atrial fibrillation. 
The percentage of stroke attributed to atrial fibrillation in the age group of 50-59 
years is only 1.5% where as in the age group of 80-89 years it is about 30.7%. 
 
 
 
 
 
 
  
Clinical guidelines 
                    American college of cardiology, the American heart association and 
the European society of cardiology recently established joint guidelines for atrial 
fibrillation management. 
                    When an episode of atrial fibrillation is first detected, it should be 
described according to whether it is symptomatic or not, or self limited or not. 
Atrial fibrillation is considered to be recurrent if 2 or more episodes have been 
documented. If atrial fibrillation terminates spontaneously it is considered to be 
“paroxysmal”. Non self terminating atrial fibrillation is considered to be persistent, 
regardless of whether cardio version is performed pharmacologically or 
electrically. If cardio version is not indicated or attempted and the patient remains 
in atrial fibrillation, the arrhythmia is designed “permanent”. 
 
 
 
 
 
 
 
  
                                    Table 3: Clinical classification of AF 
First episode of AF 
• Symptomatic or asymptomatic 
• Self-limited or persistent 
Recurrent AF          2 or more episodes of AF lasting > 30 s 
Paroxysmal AF       Recurrent AF that has ended spontaneously 
Persistent AF         AF that requires pharmacological therapy or electrical 
cardio version for termination; may be a first episode or recurrent AF 
Permanent AF       Long-standing AF (usually > 1 yr) in which cardio 
version has failed or has not been indicated 
 Investigations 
Transthoracic echocardiography 
 Transthoracic echocardiography is performed commonly during the initial 
evaluation of atrial fibrillation, when it enables clinicians to screen for occult 
pericardial, myocardial and valvular diseases. This examination may offer clues to 
etiology of dysrrythmia and provide information that will alter the approach to 
therapy. Several studies have suggested that information acquired by transthoracic 
echocardiography can assist clinicians with the sometimes difficult decisions of 
initiating antithrombotic prophylaxis in patients with atrial fibrillation. 
Transthoracic echocardiography is limited, however by inadequate visualization of 
the left atrial appendage from where most cardio embolic events are believed to 
originate.27, 28, 29 
Transthoracic echocardiography is really necessary for the initial evaluation 
and management in patients who have a first episode of atrial fibrillation. 
Several are the disorders associated with atrial fibrillation; some of the 
most important are mitral stenosis, left ventricular hypertrophy, focal wall motion 
abnormalities suggestive of myocardial infarction, left ventricular dysfunction and 
others which are diagnosticated fast and precociously by echocardiography. The 
information on left ventricular systolic function helps to guide the choice of 
pharmacological therapy for ventricular rate control in chronic atrial fibrillation.30  
 Transesophageal echocardiography 
Transesophageal echocardiography employs a miniature, high frequency 
ultrasound mounted on a steerable endoscope to visualize the heart from within the 
esophagus, eliminating sonographic interference from the lung and chest wall that 
limits standard transthoracic view. 
 Transesophageal echocardiography is safe in the hands of an experienced 
operator but mastery of the technique requires specialized training and 
performance of an adequate number of studies to ensure high quality imaging31. 
The left atrial appendage is an intricate, frequently multilobed muscular 
extension of the left atrium that lies in close proximity to the esophagus. 
Meticulous imaging of the left atrial appendage in several planes is essential 
because of the structure’s complexity and anatomical variability among subjects. 
Veinot et al noted that 80% of specimens had multilobed appendages, with some 
demonstrating as many as four chambers32.  Pathological and echocardiographic 
studies have implicated embolism of preexisting thrombus from left atrial 
appendage as a predominant etiology of the stroke in patients with atrial 
fibrillation. 
Transesophageal echocardiography is superior to Transthoracic 
echocardiography in visualizing this structure32, and identifying the left atrial 
thrombus, with sensitivity that approaches 100%.33, 34 
 
 Figure 4 
Adipose tissue simulating thrombus in Transesophageal 
echocardiography. 
 
 
Figure 5 
Spontaneous Echo contrast in Transesophageal echocardiography. 
 
 
 
 
 
 
 
 Limitations of Transesophageal echocardiography35 
1. Thrombus identification may be challenging even if the left 
atrial appendage is visualized adequately. 
2. Several artifacts can result in misdiagnosis and lead to 
unnecessary delays in cardio version. E.g. prominent 
trabeculations, duplication artifacts, and adipose tissue with 
in the transverse sinuses. 
3. Failure to adequately image the right atrial appendage, 
where the thrombi can form and clinically result in 
pulmonary embolism if left untreated. 
 
 
 
. 
 Figure 6 
Left atrial clot in Transesophageal echocardiography. 
 
 
Figure 7 
Left atrial appendage clot in Transesophageal echocardiography. 
 
 
 
 
 
 Correlation between Transthoracic and Transesophageal echo cardiography 
A prospective study conducted by Khatouri et al showed that  
Surgical findings in pure or very predominant mitral stenosis are more closely 
correlated with Transesophageal echocardiography which tends to overestimate the 
severity of anatomical lesions, particularly valvular calcifications. Both procedure 
can act in complement to each other with Transthoracic Echocardiography done first 
to evaluate the under lying cause of Atrial fibrillation and Transesophageal 
Echocardiography used to evaluate the risk of Left atrial thrombus formation. 
Transthoracic echocardiography is used to detect the underlying abnormality which 
predisposes to the atrial fibrillation and this may be followed by the 
Transesophageal echocardiography which helps to evaluate the risk of thrombus 
formation.  
  Left Atrial Appendage Flow Velocities: 
                   In the normal state the left atrial appendage is relatively protected from 
thrombus formation by high velocity blood flow. Lower flow velocities are typical 
in atrial fibrillation however and have been associated with the presence of 
spontaneous echo contrast and clot formation.36 
  Left atrial appendage function can be assessed by pulse wave    Doppler. In patients 
in sinus rhythm, the appendage contracts once per cardiac cycle and the flow 
velocities at the ostium demonstrate a biphasic pattern with peak velocities generally 
exceeding 40 cm\sec. 
 Figure 8 
Decreased left atrial appendage flow velocity 
 
 
 
Figure 9 
Spontaneous Echo contrast in Left Atrium 
Spontaneous Echo Contrast (SEC) 
 
 
 
 
 
 
  
Gracia Fernandez et al identified three distinct flow patterns in 39 consecutive 
patients, 18 of whom were in sinus rhythm. 
Type 1 flow was characterized by distinct biphasic flow and was seen exclusively 
among patients in sinus rhythm.37 
Type 2 flow is characterized by a rapid saw toothed pattern, appreciated in 38% of 
atrial fibrillation patients and correlated with larger left atrial appendage dimensions 
and spontaneous echo contrast. 
In Type 3 flow   there is no discernible waves were detected and the incidence of the 
thrombus was high. 
A sub study of SPAF III demonstrated utility of left atrial appendage flow velocities 
to prospectively identify individuals at high risk. LAA peak flow velocities less than 
20 cm\second were associated independently with an increased risk of 
thromboembolic events with a relative risk of 1.7.38  
   Spontaneous Echo Contrast (SEC) 
Spontaneous echo contrast is identified commonly among patients with atrial 
fibrillation, and numerous investigators have been interested in the cause and 
prognostic significance of this finding. 
The wispy, smoke like ECHO reflections observed are thought to be produced 
by back scatters from red cell aggregates at low flow rates and they are markers of 
 hematological stasis and a prothrombotic environment.39, 40 Under normal conditions 
high flow velocities prevent erythrocytes from aggregating by maintaining shear 
stress. In atrial fibrillation the low flow state diminishes shear stress, leading to 
roleaux formation of red cells. Clinical, hematological and hemodynamic variables 
that have been associated independently with the presence of spontaneous echo 
contrast include age, fibrinogen levels, hematocrit, LAA velocities and 
atherosclerotic aortic plaque.39, 40, 41 
In SPAF III study dense SEC was associated independently with increased 
thromboembolic risk with a relative risk of 3.7. 
The presence of mitral regurgitation is negatively associated with SEC among 
patients with chronic atrial fibrillation, but its role in inhibiting thrombus formation 
and preventing stroke is less clear. 
Because of the frequent association between SEC and cardio embolic events, a 
thorough investigation of LAA is warranted whenever dense SEC is identified. Even 
if thrombus is not found, these patients should be considered at high risk for 
embolic events and treated appropriately. 
   Distinguishing between dense contrast and true thrombus often can be difficult, 
as the two frequently coexist. 
Despite the added prognostic information that can be acquired by 
Transesophageal echo cardiography, controversy exists as to the value of routine 
screening of all with atrial fibrillation for the purpose of risk stratification, 
 particularly those defined as low risk. The relatively low rate of thromboembolism 
in patients categorized as low risk based on clinical and standard echocardiographic 
parameters does not justify proceeding with routine TEE in this population. 
Individuals at moderate risk for both stroke and hemorrhagic complications with 
anticoagulation however may derive benefit from further risk stratification 
Mitral valve area and thrombus formation 
The incidence of thrombus in left atrium is significantly associated with mitral 
valve area in cases of mitral stenosis (a prospective study of left atrial spontaneous 
echo contrast) and also with the size of left atrium. But there are studies 
contradicting this aspect. In cases of non valvular atrial fibrillation left atrial size has 
no significant association with left atrial thrombus formation. 
 
 
 
 
 
 
 
 
  
 Table 4   :       Determinants of the Echocardiographic Mitral Valve Score 
Grade Mobility Subvalvular thickening Thickening Calcification
1 
 
Highly mobile 
valve with only 
leaflet tips 
restricted 
minimal thickening just 
below the mitral leaflets 
 
 
leaflets near normal 
in thickness 
(4-5cm) 
 
a single area of 
increased echo 
brightness 
2 
 
Leaflet mid and 
basal  
Portions have 
normal 
mobility 
Thickening of chordal 
structures extending up to 
one third of the chordal 
length 
 
 
Midleaflets  
normal, 
considerable 
thickening of 
margins 
 
 
Scattered areas 
of brightness 
confined to 
leaflet margins 
 
 
3 
 
Valve continues 
to move  
forward in 
diastole, mainly 
from the base 
Thickening extending to 
distal third of the chords 
Thickening 
extending through 
the entire leaflet (5-
8 cm) 
Brightness 
extending in to 
the midportion 
of the leaflets 
4 No or minimal forward  
movement of 
the leaflets 
 in diastole  
Extensive thickening and 
shortening of all chordal 
structures extending down 
to the papillary muscles 
Considerable 
thickening of all 
leaflet tissue (>8-10 
mm) 
Extensive 
brightness 
throughout 
much of the 
leaflet tissue 
Mitral valve severity score  
Mitral valve severity score is used to assess the severity of mitral stenosis by 
grading the mitral valve leaflet mobility, subvalvular thickening, and thickening of 
valve leaflet and calcification of leaflets. When the score is >8 mitral stenosis is 
usually severe requiring valve replacement surgery. There are few studies showing 
positive association with the incidence of left atrial thrombus and the mitral valve 
severity score.  
  
AIMS AND OBJECTIVES 
 
1. To study the clinical profile of all adult patients with atrial fibrillation 
admitted in Government Rajaji Hospital. 
2. To evaluate the cause of atrial fibrillation in these patients. 
3. To perform a comparative analysis of Transthoracic and Transesophageal 
echocardiography in atrial fibrillation. 
 Materials and Methods 
Type of study            :         Prospective analytical study 
Setting                      :          Department of Medicine, 
                                   Government Rajaji Hospital, 
                                   Madurai. 
Collaborating           :          Department of Cardiology, 
Department                         Government Rajaji Hospital, 
                                   Madurai. 
Duration of study      : August 2004 to June 2005 
Ethical clearance       : Ethical clearance was obtained. 
Consent                      : Informed consent was obtained before taking up 
                                    each case for study. 
 
Inclusion criteria        :  
All patients above 18 years of age with atrial fibrillation in Surface 
electrocardiogram were included in the study. 
The patients admitted in the medical and cardiology wards were taken for this 
study. 
 For the history of Rheumatic fever the past history with fever, migratory joint 
pain with no residual deformity were included. 
To diagnose atrial fibrillation absent p waves, fibrillatory waves, irregularly 
irregular ventricular reponse in electrocardiography were taken as the evidence for 
diagnosis. 
For evaluation regarding etiology the electrocardiograph, echocardiogram, 
chest X-ray were done in all cases. 
Chronic obstructive pulmonary disease is diagnosed with Chest X-ray, 
electrocardiograph, echocardiogram, history of chronic cough and history of smoking. 
Significant Q wave in ECG, Regional wall motion abnormality in 
echocardiography were taken as evidences for coronary artery disease. 
Thyroid profile studies were done for ‘at risk’ cases only. 
Diagnosis of hypertension was made with systolic BP > 140 mmHG and /or 
Diastolic BP > 90mmHG. 
Exclusion criteria     : 
   1.  Patients with age less than 18 years. 
                 2.  Patients who were hemodynamically unstable.                                     
 
 
 
  
Materials  
152 patients with atrial fibrillation who were above 18 years of age and 
hemodynamically stable were included in the study. 
Methods 
152 patients with atrial fibrillation were studied and their selected clinical; 
socio demographic data were included in the proforma. 
Patients age, sex, history of Coronary Artery Disease, Systemic Hypertension, 
Cardiomyopathies, Congenital Heart Disease, Thyroid dysfunctions, COPD, 
cerebrovascular accidents, transient ischemic attacks were taken in to account. 
Clinical examination 
1. Special attention for thyroid swelling,  
2. Pulse rate,  
3. Heart rate,  
4. Pulse deficit,  
5. Jugular venous pressure. 
Laboratory data 
1. 12 lead ECG with rhythm strip, 
2. Transthoracic echocardiographic examination, 
 3. Transesophageal echocardiographic examination, 
4. Thyroid function tests in appropriate patients, 
5. Blood glucose levels-fasting and post prandial, 
6. Chest X-Ray PA View. 
Transthoracic echocardiography was done in all patients and the following 
parameters were assessed. 
1. ejection fraction 
2. left atrium size 
3. left atrial clot 
4. spontaneous echo contrast 
5. mitral valve severity score 
6. mitral valve area 
All patients were analyzed with 2D ECHO, M MODE and Color Doppler to 
find out the structural heart disease like congenital heart diseases, coronary heart 
diseases, hypertensive heart disease, and dilated cardiomyopathies. Transthoracic 
echocardiographic assessment also included the search for the presence of left atrial 
thrombus, left atrial appendage thrombus, left atrial auto contrast. 
Transesophageal echocardiography was done in all patients and following 
parameters were assessed. 
  
1. left atrial appendage size 
2. left atrial appendage flow velocity(filling and emptying) 
3. left atrial thrombus 
4. spontaneous echo contrast 
5. clot size 
Transesophageal echocardiography employs a miniature, high frequency 
ultrasound transducer mounted on a steerable endoscope to visualize the heart from 
with in the esophagus, eliminating sonographic interference from the lung and the 
chest wall that limits transthoracic view. 
All patients underwent Transesophageal echocardiographic evaluation using 
ALOKA SSPPRO 2000 with multiplane TEE probe. Left atrial appendage emptying 
velocity is normally > 0.6 mt/sec. Left atrial dimension is normally 1.92 to 4 cm. 
Normal mitral valve orifice is 4-6 cm2. 
 
 
 
 
 
  
Limitations of the study 
1. Patients with age less than 18 years were not included in the study due to 
difficulty encountered during Transesophageal echocardiographic study. 
2. Atheromatous aorta which could produce thromboembolism in atrial 
fibrillation patients was not included in the study, because the association 
between the two is not well supported by studies. 
3. Transesophageal echocardiography could not effectively document thrombus 
in right atrial appendage, so the study was limited to left atrium and its 
appendage. 
4. Patients with hemodynamic instability were not included in the study so the 
association between the incidence of left atrial thrombus and the LV 
dysfunction could not be completely assessed.  
Financial support – nil 
Competing\conflicting interest- nil 
Statistical analysis – Epidemiological Information Package – 2005 was used to 
calculate the frequencies, percentages, mean, standard deviations and p values. 
A ‘p’ value less than 0.05 is taken to represent significant difference. 
 
 Results 
        Total number of patients included in our study was 152 
        Table 5: Baseline Characters 
Total Number of cases 152 
Mean age in years (SD) 35.6±10 
Males  66 (43.4%) 
Females  86 (56.6%) 
Rheumatic heart disease 134 (88%) 
Hypertension  13 
Thyrotoxicosis  4 
Atrial Septal Defect 2 
Dilated cardiomyopathy  2 
Hypertrophic 
ObstuctiveCardioMyopathy 
2 
Coronary artery disease  2 
Rheumatic heart disease                  Number of patients 
Mitral Stenosis 122 
Mitral Regurgitation  78 
Aortic Regurgitation 32 
Aortic Stenosis 6 
 
The mean age of our study population was 35.6± 10 years. Female patients were 
predominant in our study and 86 patients were female patients (57%). In our study 
majority of population had rheumatic heart disease. We divided the study population 
into rheumatic and non rheumatic group. 134 patients (88%) had rheumatic heart 
 disease and 18 patients (12%) belonged to non rheumatic group. Out of the non 
rheumatic group 6 patients had hypertension and 4 patients had Thyrotoxicosis, 2 
patients had atrial septal defect, 2 patients had dilated cardiomyopathy, 2 patients had 
Hypertrophic obstructive cardiomyopathy, 2 patients had coronary artery disease and 
7 patients had both rheumatic heart disease  and hypertension. In rheumatic heart 
disease group 122 patients (91%) had mitral stenosis. 89 of them had severe mitral 
stenosis and 25 patients had moderate mitral stenosis and 8 patients had mild mitral 
stenosis. 78 patients had mitral regurgitation, 34 patients had aortic regurgitation, 6 
patients had aortic stenosis. 
  
 
 
 
 
 
 
 
 
 
  Table 6 : Profile of our study population 
Rheumatic Heart 
Disease 
Non rheumatic Heart 
Disease 
134(88%) 18(12%) 
Thrombus No 
Thrombus 
Thrombus No 
Thrombus 
 
74 (55%) 60   (45%) 4 (27%) 14   (73%) 
AGE  34±7 34±10 40±6.9 50±8 
MALE 38(51%) 20(32%) 2(60%) 6(58%) 
FEMALE 36(49%) 42(68%) 2(40%) 8(42%) 
Left Atrial 
area in cm2 
4.7±0.3 2.5±0.3 
P=0.004 
4.5±2.1 
 
4±0.4 
P=0.641 
Left Atrial 
Appendage 
emptying  
Velocity in 
metre/sec. 
0.165 ± 
0.11 
0.31±0.08 
P=0.001 
0.169±0.17 
 
0.35±0.1 
P=0.026 
 
The study population was broadly divided into two groups namely those with 
rheumatic heart disease and those without rheumatic heart disease. About 134 patients 
had rheumatic heart disease (88%) out of which 74 patients (55%) had left atrial 
thrombus and 60 (45%) patients did not have thrombus. In those who had thrombus 
the mean size of left atrium was 4.7 cm and left atrial appendage emptying velocity 
was 0.17 m\s. In patients without thrombus the left atrial dimension was 2.5±0.3 cm, 
left atrial appendage flow emptying velocity was 0.36m\s. 
 
 Figure 10 
Causes of Atrial Fibrillation 
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Causes of Atrial fibrillation in our study 
Table 7: Causes of Atrial fibrillation in our study  
Causes No. %
       
CAD 
 
2 
 
1.3 
RHD 134 88.2 
HT 13 8.6 
CM 4 2.7 
CHD 2 1.3 
Thyroid 4 2.7 
 
                 In this study group of atrial fibrillation, predominant cause was Rheumatic 
heart disease, constituting about 134 cases (88%). Other causes grouped together 
constituted only 18 cases (12%). There was a statistically significant difference of 
0.001. Among the rheumatic heart disease group, mitral stenosis was the predominant 
cause, with 122 patients diagnosed to have mitral stenosis (91%).  
 
 
 
 
  
 
Age distribution of Rheumatic heart disease and Non Rheumatic causes of atrial 
fibrillation 
Table 8: Age distribution of Rheumatic and Non Rheumatic Atrial 
Fibrillation  
 
Rheumatic Non Rheumatic Total Age in years 
No. % No. % No. % 
< 20 14 10.4 - - 14 9.2 
20- 29 32 23.9 - - 32 21.1 
30- 39 52 38.8 2 11.1 54 35.5 
40 – 49 32 23.9 10 55.6 42 27.6 
50 & above 4 3.0 6 33.3 10 6.6 
Total 134 100 18 100 152 100 
Mean 47.44 34.13 35.7 
S.D 6.27 8.93 9.7 
'p' 0.0001( Significant) 
 
 
               Rheumatic heart disease was predominant in the middle age group in this 
study with 116 patients in the age group between 20-50 years. Only 4 patients 
were present in above 50 years age group. In the Non rheumatic causes group all 
the patients were above 30 years of age. 
 
  
Figure 11 
Comparison between Transthoracic echocardiography versus Transesophageal 
echocardiography in Atrial fibrillation 
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 Comparison between Transthoracic echocardiography and Transesophageal 
echocardiography in Arial fibrillation. 
Table 9: Transthoracic Echocardiography versus Transesophageal  
Echocardiography 
 
TTE TEE Findings 
No. % No. % 
'p' 
a) Left atrial 
Thrombosis 
44 28.9 78 51.3 0.0001 
Significant 
b) 
Spontaneous 
Echo 
Contrast 
 
34 
 
22.4 
 
114 
 
75 
 
0.0001 
Significant 
 
Transthoracic echocardiography detected left atrial thrombus in 44 patients 
(28.9%). Transesophageal echocardiography detected the presence of left atrial 
thrombus in 78 patients, which constituted around 51.3% of the entire study 
population. There was a statistically significant difference (p value= 0.0001) 
Transthoracic echocardiography detected the presence of spontaneous echo 
contrast in 34 patients (22.4%), where as Transesophageal echocardiography detected 
spontaneous echo contrast in 114 (75%). There was a statistically significant 
difference (p value= 0.0001).  
 
 
 Relationship between mitral valve area and incidence of left atrial thrombus 
Table 10: Relationship between Mitral Valve Area and Left Atrial Thrombus 
in mitral stenosis  
 
Thrombus  No Thrombus Total Mitral Valve 
Area (Cm2 ) No. % No. % No. % 
0 – 1.0 60 85.7 29 55.8 89 73 
1.1 – 1.5 10 14.3 15 28.8 25 20.5 
1.6 – 2 - - 10 15.4 8 6.5 
Mean 0.8171 1.05 0.9164 
S.D 0.2213 0.3953 0.3274 
'p' 0.0138 ( Significant) 
 
There was a direct association between the mitral valve area and incidence of left 
atrial thrombus in mitral stenosis.  In 89 patients with mitral valve area <1cm2, left 
atrial thrombus was present in 60 patients (85.7%). In patients with mitral valve 
area between 1 to 1.5 cm2 (22 patients), left atrial thrombus was present in about 
10 patients (14.3%). None of the patients with mild mitral stenosis had left atrial 
thrombus. The difference was statistically significant (p value= 0.0138) 
 
 
 
 
 
 Correlation between mitral valve severity score and incidence of left atrial thrombus 
in mitral stenosis. 
Table 11: Mitral valve Severity Score and Left Atrial Thrombus 
Thrombus No Thrombus Total Mitral valve 
Severity Score No. % No. % No. % 
<  8 10 14.3 24 46.2 34 27.8 
> 8 60 85.7 28 53.8 88 72.2 
Mean 7.74 7.08 7.46 
S.D 0.65 1.0 0.88 
'p' 0.0001 ( Significant) 
 
                   34 patients had mitral valve severity score less than 8. In this group 10 
patients had left atrial thrombus (14.3% of mitral stenosis patients with LA thrombus). 
88 patients with mitral stenosis had mitral valve severity score greater than 8. In this 
group 60 patients had left atrial thrombus (85.7% of mitral stenosis patients with LA 
thrombus). The difference was statistically significant (p value=0.0001).  
     
 
 
 
 
 
 
  Table 12 : 
 Relationship between left atrial appendage emptying velocity and left atrial 
thrombus                  
                                                                                                                               
Thrombus No Thrombus Total Left Atrial 
Appendage 
emptying 
velocity  
No. % No. % No. % 
0.1 -  0.19 62   79.5% 15 20.2 77 50.7 
0.2  - 0.29 12   15.4% 10 13.5 22 14.5 
0.3 – 0.39  4 5.1% 12 16.2 16 10.5 
0.4 and above - - 37 51.4 37 24.5 
Mean 0.17 0.37 7.46 
S.D 0.O7 0.13 0.88 
'p' 0.0001 ( Significant) 
 
77 patients had left atrial appendage emptying velocity between 0.1-0.19 
m\sec. In this group of patients 62 had left atrial thrombus and 15 patients did not 
have thrombus. 22 patients had left atrial emptying velocity between  0.2m\sec –
0.29m\sec, in this group 12 patients had left atrial thrombus. Patients with left atrial 
emptying velocity between 0.3-0.39m\sec were 16. Out of them 4 had left atrial 
thrombus. Patients with left atrial appendage emptying velocity greater than 0.4m\sec 
did not have left atrial appendage thrombus. There was a statistically significant 
relationship between the left atrial appendage emptying velocity and the incidence of 
left atrial thrombus, with a p value of 0.0001.   
 
 
 Relationship between left atrial area and incidence of left atrial thrombus 
Table 13 Relationship between left atrial size and left atrial 
thrombus  
 
Thrombus No Thrombus Total Left atrial size 
in cm(2) No. % No. % No. % 
2 - 3 5 6.4 41 55.4 46 30.3 
3.1 - 4 28 35.9 30 40.5 58 38.2 
4.1 – 5 25 32.1 3 4.1 28 18.4 
5.1 - 6 17 21.8 - - 17 11.2 
> 6 3 3.8 - - 3 2 
Mean 4.5 2.58 3.76 
S.D 1.0 0.62 1.13 
'p' 0.0001 (  Significant) 
 
46 patients had left atrial area in the range of 2-3cm2. In this group only 5 
patients had left atrial thrombus and 41 patients did not have any thrombus. 58 
patients had left atrial area in the range of 3.1-4 cm2. In this group 28 patients had left 
atrial thrombus and 30 patients did not have thrombus. 28 patients had left atrial area 
in the range of 4.1-5 cm2. In this group 25 patients had left atrial thrombus and 3 
patients did not have left atrial thrombus. All the patients with left atrial area greater 
than 6 cm2 had left atrial thrombus. The statistical significance was 0.0001. 
  
Discussion 
In our study 152 patients with atrial fibrillation were analyzed. Patients below 
18 years of age were excluded. Rheumatic heart disease was the predominant etiology 
for atrial fibrillation, in this study. 
This is in contrast to the western literature where the population studied was 
predominately whites. The most common causes were systemic hypertension and 
coronary artery disease in Western countries. 
Some Indian studies done previously had shown that Rheumatic heart disease 
as the commonest cause in our country.  
In this study rheumatic heart disease was predominant etiology for atrial 
fibrillation, 134 (88%) patients had Rheumatic heart disease. Among the Rheumatic 
heart disease, mitral stenosis was the predominant valvular disease. 122 patients 
(79%) had Rheumatic mitral stenosis. Hypertensive heart disease was the next 
common disease. 13 patients (7%) had Hypertensive heart disease. Female patients 
were predominant in number in our study and 86 patients (57%) were female patients, 
due to increased prevalence of Rheumatic mitral stenosis in female patients. 
But in Framingham study incidence of atrial fibrillation is slightly higher in 
male population compared to that of females. 
 Among the patients with rheumatic heart disease with atrial fibrillation, mitral 
stenosis was the predominant valvular heart disease, 122 patients (79%) had 
rheumatic mitral stenosis. There was a significant correlation between the incidence 
of left atrial clot and severity of mitral stenosis. This was well noticed in our study. In 
our study 89 patients (73%) had severe mitral stenosis. Out of them 68% had left 
atrial thrombus. We have noticed a marked decline in incidence of left atrial thrombus 
corresponding to decline in the severity of mitral stenosis. In those with mitral 
stenosis with moderate severity, 36% ad left atrial thrombus. None of the patients 
with mitral stenosis of mild severity had left atrial thrombus in our study. In the study 
by Srimannarayana et al, he found that left atrial clots were present in a third of 
patients with severe rheumatic mitral stenosis and atrial fibrillation42. In our study 
68% of patients with severe mitral stenosis had left atrial thrombus. 
The incidence of left atrial thrombus in patients with rheumatic heart disease in 
our study was 54%. In the study by Srimannarayanan et al patients with severe 
rheumatic mitral stenosis and atrial fibrillation were assessed by Transesophageal 
echocardiography. Of the 490 patients studied, 163 had left atrial body or left atrial 
appendage clots. Of the 490 patients who underwent TEE, left atrial clots were 
present in 163 (32.2%). Isolated left atrial appendage clots were found in 88patients 
(18%). Isolated left atrial body clots or left atrial appendage clots extending into left 
atrial body were found in 75 patients (15.3%).42 
 In a small group of 50 patients with mitral stenosis and atrial fibrillation by 
Hwang et al, the incidence of left atrial thrombus was 56%.43 
In another small study of 22 patients with mitral stenosis and atrial fibrillation 
by Karatasaki et al, left atrial thrombus was observed in 12 patients (54%).44  
These studies point towards the incidence of left atrial thrombus in up to 50% 
of patients with rheumatic mitral stenosis. 
In this study there was a significant relationship between the mitral valve 
severity score and left atrial thrombus. 34 patients (26.6%) had mitral valve score <8, 
out of them 10 patients had thrombus (32%). 88 patients (73.3%) had mitral valve 
score >8, out if them 60 patients (68%) had left atrial thrombus. 
 In the study by Karatasaki et al, in 22 patents with mitral stenosis and atrial 
fibrillation, left atrial thrombus was observed in 12 patients (54%). When the severity 
of mitral valve score is great than 8, the incidence of left atrial clot was about 68% 
and in patients with mitral valve score less than 8 it was only about 32%. Thus the 
incidence of left atrial thrombus in patients with Rheumatic mitral stenosis with atrial 
fibrillation correlates with the mitral valve severity score. The mitral valve severity 
score takes in to account the mobility, sub valvular thickening, valve thickening and 
calcification. These patients with mitral valve score >8 are at greater risk of 
thromboembolism. 
 In this study Transthoracic echocardiographic examination revealed left atrial 
clot in 44(28.9%) patients and spontaneous echo contrast was seen in 34 (22.4%) 
 patients. However Transesophageal echocardiographic examination revealed 
spontaneous echo contrast in 114 (75%) patients. Left atrial thrombus was seen in 78 
(51.3%) patients. Transesophageal echocardiography appears superior in detecting the 
presence of left atrial thrombus. This was well analyzed in various previous studies. 
In a study by Manning et al involving 23 patients, 14 patients had left atrial thrombi, 
11 of the 14 were confined to the left atrial appendage. At surgery all 12 thrombi 
identified were confirmed. In this study TEE had a sensitivity of 100% and a 
specificity of 99% for detection of left atrial thrombi. This study is also complimented 
by another study by Ashenbeg et al, in which the TEE proved to be superior to TEE in 
visualizing the left atrial appendage and identifying the left atrial thrombus and with 
sensitivity that approaches 100%. Thus TEE has got a definite superiority in detecting 
left atrial thrombus as well as left atrial appendage thrombus as compared with TTE. 
              In this study population spontaneous echo contrast was seen in 
32(21%) patients in transthoracic echocardiography. However Transesophageal 
echocardiographic examination revealed spontaneous echo contrast in 114(75%) 
patients. In the study by Fatkins et al Transthoracic echocardiographic studies were 
performed in 140 patients with atrial fibrillation. Left atrial spontaneous echo contrast 
was present in 78 patients (56%). Increasing grades of spontaneous echo contrast 
were associated with decreasing left atrial appendage blood velocity. In multivariate 
linear regression analysis, the grade of spontaneous echo contrast was significantly 
and negatively associated with left atrial appendage velocity (p =0.001) and 
 significantly46. Spontaneous echo contrast is the cardiac factor most strongly 
associated with left atrial appendage thrombus and embolic events. 
In Stroke Prevention in Atrial Fibrillation (SPAF III) study, dense spontaneous 
echo contrast was associated independently with increased thromboembolic risk with 
a relative risk of 3.7. Because of the frequent association between spontaneous echo 
contrast and cardio embolic events, a thorough investigation of the left atrial 
appendage is warranted whenever dense spontaneous echo contrast is identified. Even 
if thrombus is not found these patients should be considered as high risk for embolic 
events and treated appropriately. 
In this study Transesophageal echocardiography proved to be far better in 
eliciting the risk factors for thromboembolic in patients with atrial fibrillation, when 
compared to that of transthoracic echocardiography. In the BEST trial comparing 
Transesophageal echocardiography to surgical findings, sensitivity of 
Transesophageal echocardiography to left atrial thrombus was 100% and specificity 
of 99%. Transesophageal echocardiography has a higher sensitivity than transthoracic 
echocardiography for spontaneous echo contrast. Spontaneous echo contrast was 
detected by Transesophageal echocardiography in 25 – 45% of atrial fibrillation 
patients and in >80% of those with atrial fibrillation and left atrial thrombus47. 
Transesophageal echo offers unique imaging resolution of the left atrium and 
its appendage and is an excellent tool for detecting embolic sources. Transesophageal 
Echocardiographic features that are independently associated with increased 
 thromboembolic risk are appendage thrombi, dense spontaneous echo contrast, left 
atrial appendage peak velocity <20 cm\sec. In this study patient with left atrial 
appendage emptying velocity less than 0.2m\sec had increased incidence of left atrial 
thrombus. This study correlates well with the study conducted by Fatkins et al .46 
In this study there was a strong correlation between size of left atrium and the 
incidence of left atrial thrombus. The mean size of the left atrium was 4.5 cm2 in 
patients who had left atrial thrombus; where as the mean left atrial size was around 
2.5 cm2 in patients with out thrombus. 
 
 
 
 
 
 
 
 
 
 
 
 CONCLUSION 
1. Rheumatic heart disease was the most common cause of atrial fibrillation in this 
study. 
2. Rheumatic mitral stenosis was the most common valvular lesion associated with atrial 
fibrillation. 
3. Transesophageal echocardiography was superior to transthoracic echocardiography, 
regarding the evaluation of atrial fibrillation, because of its better sensitivity to left 
atrial thrombus as well as spontaneous echo contrast. 
4. In Rheumatic mitral stenosis mitral valve severity score correlates with the incidence 
of left atrial thrombus. Mitral valve score >8 had thrombus had thrombus in 68% 
where as left atrial thrombus was present in 26.6% of patients with mitral valve score 
<8.  
5. In Rheumatic mitral stenosis, valve area also correlated with the incidence of left 
atrial thrombus. 73% of patients with severe mitral stenosis had left atrial thrombus; 
where as none of the patients with mild mitral stenosis had left atrial thrombus. 
6.  Patients with left atrial appendage emptying velocity <0.2m/sec had increased 
incidence of left atrial thrombus in this study. 
7. Patients with left atrial size > 4.5 cm2 had increased incidence of thrombus formation 
in the left atrium in patients with atrial fibrillation in this study. 
 SUMMARY 
Atrial fibrillation is the most common sustained cardiac arrhythmia and 
represents the most common clinically significant cardiac arrhythmia. It is the most 
common cause of embolisation from cardiac source leading to cerebrovascular 
accident. The study was undertaken to study the clinical profile, under lying causes of 
atrial fibrillation and also to do a comparative analysis of findings in Transthoracic 
and Transesophageal echocardiography in patients with atrial fibrillation. 
Thus 152 patients with atrial fibrillation were taken up for study, after 
excluding the patients with age <18 years of age. After institutional ethical clearance, 
and an informed consent, the patient’s sociodemographic, clinical and laboratory data 
were collected and analyzed statistically. 
Mean age of study population was 35.7±10 years. Female patients were 
predominant in our study. 86 patients (56.6%) were female patients. 
Predominant number of patients in our study group belonged to rheumatic 
heart disease, with 134 patients (88%) had rheumatic heart disease and 18 patients 
(12%) belonged to non rheumatic group. Systemic hypertension was second most 
common cause. 
In rheumatic heart disease group 122 patients (122\152) had mitral stenosis. 
Out of those with mitral stenosis, 89 patients had severe mitral stenosis 25 patients 
had moderate mitral stenosis and 8 patients had mild mitral stenosis. 
 Thus rheumatic mitral stenosis was the most common cause of atrial 
fibrillation in this study with slight female predilection. 
The incidence of left atrial thrombus had a direct correlation to the severity of 
the mitral stenosis. In this study 89 patients had severe mitral stenosis and out of them 
68% had left atrial thrombus, where as in patients with moderately severe mitral 
stenosis only 36% had left atrial thrombus and in patients with mild mitral stenosis 
none had left atrial thrombus. 
In this study, patients with mitral valve severity <8 were about 34, out of them 
10 patients (26%) had left atrial thrombus. 88 patients (72.2%) had mitral valve 
severity score >8 and out of them 60 patients (68%) had left atrial thrombus. Thus 
severity of mitral stenosis and mitral valve score correlated with the incidence of left 
atrial clot in patients with mitral stenosis. 
In this study patients underwent transthoracic echocardiographic evaluation 
followed by Transesophageal echocardiographic evaluation. 
Transthoracic echocardiography detected left atrial thrombus in 44 patients 
(28.9%), where as Transesophageal echocardiography showed left atrial thrombus in 
78 patients (51.3%). 
Like wise, Transthoracic echocardiography detected spontaneous echo contrast 
in 34 patients (22.4%). Transesophageal echocardiography revealed spontaneous echo 
contrast in 114 patients (75%). 
 Thus in this study Transesophageal echocardiography proved to be superior to 
Transthoracic echocardiography, regarding the detection of left atrial thrombus as 
well as detection of spontaneous echo contrast. 
Patients with left atrial appendage flow velocity in range of 0.2m\sec had 
increased risk of thrombus formation 
Patients with left atrial size around 4.5 cm2 had statistically significant risk of 
thrombus formation. 
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 PROFORMA 
 ATRIAL FIBRILLATION; CLINICAL, TRATHORACIC 
ECHOCARDIOGRAPHY AND TRANSESOPHAGEAL 
ECHOCARDIOPATHY CORRELATION 
 
NAME     C.D. NO 
 
AGE      I.P. NO. 
 
SEX      WARD NO.   DOA 
 
OCCUPATION    UNIT    DOD 
 
DIAGNOSIS : 
CAUSE OF ATRIAL FIBRILLATION : 
 
HISTORY : 
 
 Risk Factors : 
 Age > 65 Yrs CAD  CHF  COPD  DM 
 Previous History of TIA / Stroke 
Significant Valvular Heart Disease 
Hypertension 
 
General Examination : 
 
Heart Rate :  B.P   BUILT 
Pulse Rate :  Tremor  Eye Signs 
Pulse Deficit 
 
Cardiovascular System : JVP 
 Mitral Area 
  Tricuspid Area 
 Aortic Area 
 Pulmonary Area 
 
Respiratory System  : 
Per Abdomen : 
Central Nervous System : 
 
Investigations 
 
ECG Rate    Rhythm P-R Interval  QRS Duration 
 P-Axis    QRS Axis ST-T Changes     LAE    RAE   LVH    RVH 
CXR 
Trans Thoracic Echo : 
LVIDd    LVIDs   EF 
IVSs    IVSd 
LVPWs   LVPWd 
RWMA 
 
DOPPLER 
 
MV  E  A  E/A  DT 
IVRT 
 
TRANS ESOPHAGEAL ECHOCARDIOGRAPHY 
LA Size 
LV functional status 
Spontaneous Echo Contrast 
LA appendage emptying velocity 
Complex Aortic Atheroma 
 LA clot 
 
LVID - Left ventricular internal Diameter    
d- diastolic  
s- systolic 
 
IVS  - Inter ventricular septum 
d- diastolic  
s- systolic 
 
EF - Ejection Fraction 
 
LVPW - Left ventricular posterior Wall 
d- diastolic  
s- systolic 
 
RWMA - Regional Wall Motion Abnormality 
 
MV  - Mitral Valve 
 
IVRT  - Iso volumetric relaxation time 
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1 34 2 - + - - - - - 3.3 + + 2+ 2+ 2+ 2+ 8 0.9 II - - 3.6 0.1 1 1.1 
2 18 1 - + - - - - - 5.9 - - 2+ 2+ 2+ - 6 1.3 II 1 - 3.2 0.23 1 0.91 
3 47 1 - - - - - + - 2.5  - -                   2 0.4 2   
4 19 2 - + - - - - - 3.1 - - 2+ 2+ 2+ 2+ 8 0.7 - - - 2.7 0.4 2   
5 36 1 - + - - - - - 3.2 - - 2+ 2+ 2+ - 6 1.5 II II - 3.9 0.5 2   
6 28 1 - + - - - - - 4.7 - - 2+ 2+ 2+ - 6 1.3 II - - 3.1 0.12 1 0.42 
7 27 2 - + - - - - + 4 + - 2+ 2+ 2+ 2+ 8 0.8 I - - 3.9 0.12 1 6.93 
8 54 2 - - - - + - -  2.1 - -                   3.1 0.15 2   
9 32 2 - + - - - - - 4 + - 2+ 2+ 2+ 2+ 8 0.7 I II - 3.2 0.19 1 0.72 
10 34 1 - + - - - - - 3.2 + - 2+ 2+ 2+ - 6 1.2 I - - 3.4 0.2 1 1.4 
11 56 2 - + - - - - - 4.6 - - 2+ 2+ 2+ 2+ 8 0.8 I - - 3.7 0.25 1 1.8 
12 18 2 - + - - - - - 4 - - 2+ 2+ 2+ - 6 1.6 II - - 3.4 0.4 2   
13 32 1 - + - - - - - 5 - - 2+ 2+ 2+ 2+ 8 0.7 I - - 3.2 0.4 2   
14 26 1 - + - - - - - 4.5 - - 2+ 2+ 2+ 2+ 8 0.9 - - II 3.6 0.19 1 1.19 
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21 26 2 - + - - - - + 5.3 + - 2+ 2+ 2+ 2+ 8 0.7 I II II 5.7 0.1 1 1.87 
22 33 2 - + - - - - - 4 - - 2+ 2+ 2+ - 6 1.6 II - - 2 0.4 2   
23 27 1 - + - - - - - 5 + - 2+ 2+ 2+ 2+ 8 0.8 - - - 3.4 0.1 1 0.11 
24 46 2 - - + - - - - 3.2  - -                   4 0.4 2   
25 26 2 - + - - - - + 5 - + 2+ 2+ 2+ 2+ 8 0.6 - - - 3.1 0.27 1 0.84 
26 48 2 - - + - - - -  2.5 - -                   3.2 0.4 2   
27 46 2 - + - - - - - 5.9 - - 2+ 2+ 2+ 2+ 8 0.7 II - - 3.6 0.1 1 1.32 
28 18 1 - + - - - - - 4.5 - -             II - - 3.6 0.4 2   
29 36 2 - + - - - - - 3.5 - -             II I - 3.1 0.5 2   
30 32 1 - + - - - - - 5 + + 2+ 2+ 2+ 2+ 8 0.8 II - - 5.9 0.15 1 1.32 
31 34 1 + - - + - - -  2.4 - -                   3.1 0.24 1 1.1 
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32 19 2 - + - - - - - 5.9 - - 2+ 2+ 2+   6 1.7 - I - 5.9 0.5 2   
33 38 2 - + - - - - - 5.8 - + 2+ 2+ 2+ 1 7 1.5 - I - 5.9 0.13 1 0.63 
34 46 2 - - -   - - +  2.3 - -                   3 0.15 1 7.82 
35 41 2 - + - - - - - 5 - - 2+ 2+ 2+ 2+ 8 0.8 I - - 2.1 0.15 1 0.48 
36 36 1 - + - - - - - 6.8 + - 2+ 2+ 2+ 2+ 8 0.6 - - - 3 0.15 1 1.12 
37 44 1 - + - - - - - 5.6 - -             I - - 4.4 0.16 1 1.17 
38 36 2 - + - - - - - 3.8 - - 2+ 2+ 2+ 2+ 8 0.8 - - - 4 0.12 1 0.8 
39 52 1 - - - + - - -  2.6 - -                   2.1 0.4 2   
40 19 2 - + - - - - - 3.5 - - 2+ 2+ 2+ - 6 1.2 I - - 2 0.2 2   
41 45 2 - + - - - - - 3.6 - + 2+ 2+ 2+ 1 6 1.7 - - - 2 0.3 2   
42 48 1 - + - - - - - 3.5 - -             - - - 2 0.4 2   
43 44 1 - + - - - - - 4.5 - - 2+ 2+ 2+ 2+ 8 0.7 - - - 2 0.3 2   
44 33 1 - + - - - - - 3.8 + - 2+ 2+ 2+ - 6 1.2 - - - 4 0.15 1 0.36 
45 36 2 - + - - - - - 4.8 + - 2+ 2+ 2+ 2+ 8 0.7 - - - 4 0.17 2   
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52 38 2 - + - - - - - 4 - + 2+ 2+ 2+ 2+ 8 0.7 - - - 2 0.38 2   
53 49 2 - + - - - - - 4 - + 2+ 2+ 2+ 2+ 8 0.6 - - - 2 0.4 2   
54 47 2 - + - - - - - 3 - + 2+ 2+ 2+ 2+ 8 0.9 - - - 4 0.13 1 1.68 
55 45 2 - + - - - - - 5.4 - - 2+ 2+ 2+ 2+ 8 0.7 II - - 1.8 0.38 2   
56 44 1 - + - - - - - 3.8 - + 2+ 2+ 2+ 2+ 8 0.8 II - - 4 0.18 1 1.43 
57 28 2 - + - - - - - 3 - - 2+ 2+ 2+ 2+ 8 0.7 - - - 1.4 0.13 1 0.84 
58 42 2 - + - - - - - 3 - -       II II - 1.6 0.4 2  
59 46 1 - + - - - - - 4 + + 2+ 2+ 2+ 2+ 8 0.9 - II - 1.8 0.4 2   
60 29 1 - + - - - - - 4.8 - - 2+ 2+ 2+ 2+ 8 0.8 II - - 3.6 0.14 1 1.12 
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65 54 2 - - - - + - - 5.4 - -                   1.8 0.38 2   
66 36 2 - + - - - - - 4 + - 2+ 2+ 2+ 2+ 8 0.8 I II - 3.2 0.17 1 0.7 
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67 38 1 - + - - - - - 3.2 + - 2+ 2+ 2+ - 6 1.4 I - - 3.4 0.2 2   
68 55 2 - + - - - - - 6.6 - - 2+ 2+ 2+ 2+ 8 0.7 I - - 3.7 0.4 2   
69 44 2 - - + - - - - 4 - - 2+ 2+ 2+ - 6 1.3 - - - 3.2 0.3 2   
70 19 2 - + - - - - - 6 - - 2+ 2+ 2+ - 6 1.2 III - - 3.4 0.4 2   
71 32 1 - + - - - - - 5 - - 2+ 2+ 2+ 2+ 8 0.7 I - - 3.2 0.4 2   
72 27 1 - + - - - - - 6 - - 2+ 2+ 2+ - 6 1.4 III - - 3.4 0.4 2   
73 56 1 - - - - - + - 5 - -                   3.4 0.4 2   
74 29 1 - + + - - - - 4 + + 2+ 2+ 2+ 2+ 8 0.7 I I - 3.5 0.12 1 0.84 
75 44 1 - + + - - - - 5 + + 2+ 2+ 2+ 2+ 8 0.6 - - - 5 0.13 1 1.28 
76 28 2 - + - - - - - 5.3 + - 2+ 2+ 2+ 2+ 8 0.8 I II II 5.7 0.1 1 1.12 
77 32 2 - + - - - - - 4 - - 2+ 2+ 2+ - 6 1.5 II - - 2 0.4 2   
78 26 1 - + - - - - - 5 + - 2+ 2+ 2+ 2+ 8 0.7 - - - 3.4 0.1 1 1.87 
79 28 1 - + - - - - - 5 + + 2+ 2+ 2+ 2+ 8 0.6 I - - 3.8 0.19 1 0.77 
80 34 2 - + - - - - - 4 + + 2+ 2+ 2+ 2+ 8 0.9 II - - 3.5 0.12 1 1.1 
81 18 1 - + - - - - - 4.6 - - 2+ 2+ 2+ - 6 1.3 II 1 - 3.7 0.2 1 0.91 
82 19 2 - + - - - - - 5.9 - - 2+ 2+ 2+ 2+ 8 0.7 - - - 3.6 0.1 2   
83 36 1 - + - - - - - 3.8 - - 2+ 2+ 2+ - 6 1.5 II II - 4 0.2 2   
84 46 2 - - + - - - -  2.7 - -                   3 0.15 2   
85 28 1 - + - - - - - 1.5 - - 2+ 2+ 2+ - 6 1.3 II - - 4 0.1 1 0.42 
86 27 2 - + - - - - + 4 + - 2+ 2+ 2+ 2+ 8 0.8 I - - 3.9 0.2 1 6.93 
87 32 2 - + - - - - - 5.9 + - 2+ 2+ 2+ 2+ 8 0.7 I II - 3.2 0.23 1 0.72 
88 34 1 - + - - - - - 4 + - 2+ 2+ 2+ - 6 1.2 I - - 2 0.18 1 1.4 
89 56 2 - + - - - - - 3.5 - - 2+ 2+ 2+ 2+ 8 0.8 I - - 2 0.14 1 1.8 
90 18 2 - + - - - - - 5 - - 2+ 2+ 2+ - 6 1.6 II - - 5 0.2 2   
91 32 1 - + - - - - - 3.5 - - 2+ 2+ 2+ 2+ 8 0.7 I - - 2 0.2 2   
92 48 2 - - + - - - - 5 - -                   3.2 0.4 2   
93 26 1 - + - - - - - 3.3 - - 2+ 2+ 2+ 2+ 8 0.9 - - II 3.6 0.16 1 1.19 
94 34 2 - + - - - - + 4 - - 2+ 2+ 2+ 2+ 8 0.7 I II - 2 0.17 1 7.13 
95 28 2 - + - - - - - 5 - - 2+ 2+ 2+ - 6 1.3 II II - 3.4 0.1 2   
96 31 1 - + - - - - -  2.2 - -             II II - 3.1 0.15 2   
97 28 1 - + + - - - - 4 + + 2+ 2+ 2+ 2+ 8 0.8 I I - 2 0.18 1 0.7 
98 42 1 - + + - - - - 4.8 + + 2+ 2+ 2+ 2+ 8 0.6 - - - 4 0.17 1 0.42 
99 26 2 - + - - - - + 5 + - 2+ 2+ 2+ 2+ 8 0.7 I II II 3.1 0.2 1 1.87 
100 33 2 - + - - - - - 4.7 - - 2+ 2+ 2+ - 6 1.6 II - - 3.1 0.12 2   
101 52 1 - - - + - - - 3 - -                   1.6 0.4 2   
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102 27 1 - + - - - - - 4.5 + - 2+ 2+ 2+ 2+ 8 0.8 - - - 3.6 0.19 1 0.11 
103 26 2 - + - - - - + 5 - + 2+ 2+ 2+ 2+ 8 0.6 - - - 4 0.15 1 0.84 
104 46 2 - + - - - - - 4 - - 2+ 2+ 2+ 2+ 8 0.7 II - - 3.2 0.2 1 1.32 
105 18 1 - + - - - - -  2.3 - -             II - - 4 0.4 2   
106 34 1 + - - + - - - 5.3 - -                   5.7 0.1 1 1.1 
107 36 2 - + - - - - - 3.5 - -             II I - 1.8 0.4 2   
108 32 1 - + - - - - - 4 + + 2+ 2+ 2+ 2+ 8 0.8 II - - 2 0.14 1 1.32 
109 19 2 - + - - - - - 3 - - 2+ 2+ 2+   6 1.7 - I - 1.4 0.3 2   
110 38 2 - + - - - - - 4.5 - + 2+ 2+ 2+ 1 7 1.5 - I - 3.6 0.19 1 0.63 
111 41 2 - + - - - - - 3.1 - - 2+ 2+ 2+ 2+ 8 0.8 I - - 2.7 0.16 1 0.48 
112 36 1 - + - - - - - 5 + - 2+ 2+ 2+ 2+ 8 0.6 - - - 3.4 0.1 1 1.12 
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114 36 2 - + - - - - - 3.8 - - 2+ 2+ 2+ 2+ 8 0.8 - - - 1.8 0.13 1 0.8 
115 19 2 - + - - - - -  2.7 - - 2+ 2+ 2+ - 6 1.2 I - - 2 0.4 2   
116 45 2 - + - - - - - 4 - + 2+ 2+ 2+ 1 6 1.7 - - - 1.8 0.4 2   
117 48 1 - + - - - - - 3.6 - -             - - - 2 0.3 2   
118 44 1 - + - - - - - 5 - - 2+ 2+ 2+ 2+ 8 0.7 - - - 5 0.2 2   
119 33 1 - + - - - - - 3.2 + - 2+ 2+ 2+ - 6 1.2 - - - 3.9 0.17 1 0.36 
120 36 2 - + - - - - - 3.5 + - 2+ 2+ 2+ 2+ 8 0.7 - - - 3.1 0.5 2   
121 37 1 - + - - - - - 5 + - 2+ 2+ 2+ 2+ 8 0.6 - II - 2 0.12 1 0.52 
122 42 2 - + - - - - - 5 - - 2+ 2+ 2+ 2+ 8 0.6 - - - 4 0.18 2   
123 34 2 - + - - - - -  2.1 + - 2+ 2+ 2+ 2+ 8 0.7 - - - 2 0.11 1 1.12 
124 31 2 - + - - - - -  3.5 - -             - - - 2.1 0.1 1 1.17 
125 46 2 - - -   - - + 5 - -                   2.1 0.25 1 7.82 
126 36 1 - + - - - - - 6.6 - - 2+ 2+ 2+ 2+ 8 0.8 II - - 3.7 0.17 1 1.3 
127 38 2 - + - - - - - 5 - + 2+ 2+ 2+ 2+ 8 0.7 - - - 4 0.1 2   
128 49 2 - + - - - - - 5.9 - + 2+ 2+ 2+ 2+ 8 0.6 - - - 5.9 0.5 2   
129 47 2 - + - - - - - 4 - + 2+ 2+ 2+ 2+ 8 0.9 - - - 3.4 0.13 1 1.68 
130 45 2 - + - - - - - 4 - - 2+ 2+ 2+ 2+ 8 0.7 II - - 3.2 0.29 2   
131 44 1 - + - - - - - 4.5 - + 2+ 2+ 2+ 2+ 8 0.8 II - - 2 0.3 1 1.43 
132 28 2 - + - - - - - 4.8 - - 2+ 2+ 2+ 2+ 8 0.7 - - - 3.6 0.14 1 0.84 
133 42 2 - + - - - - - 5 - -             II II - 3.8 0.2 2   
134 46 1 - + - - - - - 5.3 + + 2+ 2+ 2+ 2+ 8 0.9 - II - 5.7 0.1 2   
135 29 1 - + - - - - - 5.6 - - 2+ 2+ 2+ 2+ 8 0.8 II - - 4.4 0.26 1 1.12 
136 27 2 - + - - - - - 4 - - 2+ 2+ 2+ 2+ 8 0.7 II - - 2.4 0.4 2   
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137 32 2 - + - - - - - 3.2 - + 2+ 2+ 2+ 2+ 8 0.8 - - - 3.4 0.2 2   
138 36 2 - + - - - - - 5 - + 2+ 2+ 2+ 2+ 8 0.7 - - - 4 0.2 2   
139 44 2 - + - - - - - 3.2 - - 2+ 2+ 2+ 2+ 8 0.6 - - - 3.4 0.2 1 1.54 
140 36 2 - + - - - - - 2.8  + - 2+ 2+ 2+ 2+ 8 0.8 I II - 3.2 0.0.2 1 0.7 
141 38 1 - + - - - - - 4 + - 2+ 2+ 2+ - 6 1.4 I - - 3.5 0.12 2   
142 55 2 - + - - - - - 3.8 - - 2+ 2+ 2+ 2+ 8 0.7 I - - 4 0.18 2   
143 44 2 - - + - - - - 6.8 - - 2+ 2+ 2+ - 6 1.3 - - - 3 0.15 2   
144 19 2 - + - - - - - 4 - - 2+ 2+ 2+ - 6 1.2 III - - 2.1 0.3 2   
145 32 1 - + - - - - - 5 - - 2+ 2+ 2+ 2+ 8 0.7 I - - 3.2 0.4 2   
146 27 1 - + - - - - - 5.8 - - 2+ 2+ 2+ - 6 1.4 III - - 5.9 0.13 2   
147 29 1 - + - - - - - 4 + + 2+ 2+ 2+ 2+ 8 0.7 I I - 2 0.28 1 0.84 
148 44 1 - + + - - - - 4 + + 2+ 2+ 2+ 2+ 8 0.6 - - - 3.2 0.22 1 1.28 
149 28 2 - + - - - - -  2.6 + - 2+ 2+ 2+ 2+ 8 0.8 I II II 3.1 0.11 1 1.12 
150 32 2 - + - - - - - 6 - - 2+ 2+ 2+ - 6 1.5 II - - 3.4 0.4 2   
151 26 1 - + - - - - - 3 + - 2+ 2+ 2+ 2+ 8 0.7 - - - 4 0.13 1 1.87 
152 28 1 - + - - - - - 5 + + 2+ 2+ 2+ 2+ 8 0.6 I - - 5.9 0.15 1 0.77 
 
Sex -  1 Male:  2 Female 
CAD -  Coronary Artery Disease 
RHD -  Rheumatic Heart Disease 
HT -  Hyper Tension 
CM -  Cardio Myopathy 
CHT -  Congenital Heart Disease 
CVA -  Cerebro Vascular Accident 
TTE -  Trans Thoracic Echo Cardiography 
TEE -  Trans Esophageal Echo Cardiography 
SVA -  Sub-Vavular Apparatus 
MS -  Mitral Stenosis 
MR -  Mitral Regurgitation 
AR -  Aortic Regurgitation 
AS -  Aortic Stenosis 
LAA -  Left Atrial Appendage 
SEC -  Spontaneous Echo Contrast 
 
